NeurogesX (NGSX)
NeurogesX Key Statistics
Pro Data ExportCurrent Valuation
Dividends and Shares
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Dividend Date | |
| Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin | |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
| Profit Margin | -375.8% |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | -14.74% |
| Year to Date Stock Returns | -57.39% |
| 1 Year Stock Returns | -86.38% |
| 3 Year Stock Returns | -93.52% |
| 52 Week High | 4.470 |
| 52 Week Low | 0.31 |
Income Statement
| Revenues TTM | 11.31M |
| Revenue Per Share TTM | 0.378 |
| Revenue Growth | -6.21% |
| Gross Profit TTM | 10.73M |
| EBITDA TTM Pro | Go Pro |
| Income from Cont. Ops Pro | Go Pro |
| Net Income TTM | -47.35M |
| Earnings Per Share TTM | -1.93 |
| Other Comprehensive Income Pro | Go Pro |
Cash Flow Statement
| Cash Investing TTM | |
| Cash Financing TTM | |
| Cash Operations TTM | |
| Capital Expenditures | 0.00 |
Share Statistics
| Shares Outstanding | 29.91M |
Balance Sheet
| Cash and ST Investments | |
| Total Assets | |
| Liabilities | |
| Book Value | |
| Book Value per Share | |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
| Long Term Debt | 0.00 |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
You may also be interested in these NGSX related companies
NGSX News
@gofigure $PPHM $NGSX $GALE short term yes, but Long term no they are not done! All have huge potential for big gains!
about 31 days ago by BiopharmaPro
about 31 days ago by BiopharmaPro
NeurogesX to Hold Conference Call to Discuss First Quarter 2012 Results
Apr 27, 9:00AM GlobeNewswire
Apr 27, 9:00AM GlobeNewswire
$ngsx Hearings are typically scheduled 30 to 45 days from the company's request
about 35 days ago by bood747
about 35 days ago by bood747
@rickz $ngsx supposed to delist tomorrow.I cant find any news on whether thye got a hearing or not.any info?
about 35 days ago by bood747
about 35 days ago by bood747
RT @dkcba007 RT @micheleciani No i'm not kidding, 3/4 portfolio in $OCZ 1/4 BIT:ISP $PPHM $NGSX $GALE -- HAHAHAHAHAHA
about 36 days ago by studatnu
about 36 days ago by studatnu
RT @micheleciani No i'm not kidding, 3/4 portfolio in $OCZ 1/4 BIT:ISP $PPHM $NGSX $GALE I'm all IN What is your Average in $NGSX
about 36 days ago by dkcba007
about 36 days ago by dkcba007
NeurogesX Receives Determination Letter From NASDAQ; Not Regaining Compliance
Apr 20, 4:06PM Benzinga
Apr 20, 4:06PM Benzinga
No i'm not kidding, 3/4 portfolio in $OCZ 1/4 BIT:ISP $PPHM $NGSX $GALE I'm all IN
about 40 days ago by micheleciani
about 40 days ago by micheleciani
$NGSX performing well today, if will go OUT in the upper part of the triangle in 1 day we go pair http://chart.ly/eutswy8
about 41 days ago by micheleciani
about 41 days ago by micheleciani
$NGSX NeurogesX Engages JSB-Partners to Execute Business Development Strategy http://stks.co/3NGe
about 44 days ago by HulkHogan
about 44 days ago by HulkHogan
$NGSX $PPHM both green today. We are IN lightly here too holding for the $1
about 44 days ago by micheleciani
about 44 days ago by micheleciani
NeurogesX (NGSX) Gets FDA Acceptance for End-of-Phase 2 Meeting for NGX-1998
Apr 11, 7:33AM Street Insider
Apr 11, 7:33AM Street Insider
Wedbush Upgrades NeurogesX, Inc. (NGSX) to Outperform; Restructuring Puts NGX-1998 Liquid Formulation On Center Stage
Mar 14, 1:50PM Street Insider
Mar 14, 1:50PM Street Insider
NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Full Year 2011 Results
Feb 29, 8:30AM GlobeNewswire
Feb 29, 8:30AM GlobeNewswire
NeurogesX (NGSX) Confirms FDA Panel Did Not Recommend Approval of Qutenza
Feb 09, 5:47PM Street Insider
Feb 09, 5:47PM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NGSX | 0.35 | -0.02 | -5.41% | 11.07M |
| NGB | 16.30 | -0.25 | -1.51% | |
| NG | 5.91 | +0.15 | +2.60% | 1.601B |
| NFZ | 14.65 | -0.02 | -0.14% | |
| NE | 32.61 | -1.54 | -4.51% | 8.612B |
| NDX | 2559 | +31.92 | +1.26% | |
| NDSN | 53.62 | -0.48 | -0.89% | 3.527B |
| NDAQ | 21.82 | -0.40 | -1.80% | 3.853B |
| NCZ | 7.89 | -0.20 | -2.47% | |
| NCV | 8.73 | -0.16 | -1.80% |
